| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enGene Holdings Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 195,000 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENGN | enGene Holdings Inc. | 30 Jan 2026 | 1 | $0 | 4 | Chief Scientific Officer | 03 Feb 2026, 16:13 |
| ENGN | enGene Holdings Inc. | 29 Jan 2025 | 1 | $0 | 4 | Chief Scientific Officer | 31 Jan 2025, 16:38 |
| ENGN | enGene Holdings Inc. | 21 Oct 2024 | 1 | $0 | 4 | Chief Scientific Officer | 22 Oct 2024, 16:08 |
| ENGN | enGene Holdings Inc. | 18 Mar 2024 | 2 | +$47,117 | 4 | Chief Technology Officer | 20 Mar 2024, 16:42 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 9 | $0 | 4 | Chief Technology Officer | 02 Nov 2023, 16:10 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 0 | $0 | 3 | Chief Technology Officer | 31 Oct 2023, 18:02 |